Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
4,404,649
-
Total 13F shares
-
3,109,553
-
Share change
-
+41,875
-
Total reported value
-
$7,213,648
-
Price per share
-
$2.32
-
Number of holders
-
16
-
Value change
-
+$110,262
-
Number of buys
-
7
-
Number of sells
-
4
Institutional Holders of Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) as of Q1 2023
As of 31 Mar 2023,
Tempest Therapeutics, Inc. - Common Stock, par value $0.001 per share (TPST) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,109,553 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, FIL Ltd, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and NORTHERN TRUST CORP.
This page lists
16
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.